Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes
January 1998
Sanofi Winthrop and Bristol-Myers Squibb will soon promote Plavix (clopidogrel) to prevent recurrent heart attacks or ischemic strokes.
It'll be out in the next few months in the U.S. and Canada.
Plavix is a new platelet inhibitor. It's similar to Ticlid (ticlopidine)...but without the risk of neutropenia.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive